Solazyme says commercial production of renewable algal oils at Iowa plants

Solazyme (SZYM) says commercial operations have begun at both ADM's Clinton, Iowa facility, and the downstream companion facility operated by American Natural Products in Galva, Iowa.

Production at the ADM and ANP facilities is expected to ramp to a nameplate capacity of 20K metric tons/year within 12-18 months, with targeted potential expansion to 100K metric tons/year in subsequent years.

From other sites
Comments (11)
  • ShowMe9022741
    , contributor
    Comments (46) | Send Message
    And? Who are they going to be selling it to and at what price?
    30 Jan 2014, 05:59 PM Reply Like
  • Str8ghtShooter
    , contributor
    Comments (138) | Send Message
    You're not serious are you?


    Not only did Solazyme provide a list of the customers to investors but they also gave a list of target ASPs for these oils.


    And guess what? On the February 2014 Conference Call Solazyme surprised everyone by publishing ASPs that were even higher than expected for Clinton: ASPs ranged up to $3,700/MT with an average ASP of ~$2,600/MT


    ASP means Average Selling Price in case you don't know this.


    Customers include those in metalworking, lubricants, and home/personal care: Koda, Goulston, Blaser and others.


    More information here if you need.


    Good luck to you because here comes Moema (100,000 MT facility)
    30 Apr 2014, 10:27 AM Reply Like
  • gilgit
    , contributor
    Comments (41) | Send Message
    As a long-patient investor in SZYM, I immensely appreciate these interim updates of production progress in between conference calls.


    30 Jan 2014, 06:00 PM Reply Like
  • Glslack
    , contributor
    Comments (8) | Send Message
    stock is still avaiable, but not for long.
    This is a wakeup call. Institutions will own this before long.
    You may have missed Apple, Google, Facebook, Amazon, Tesla, 3D, but you don't have to miss this.
    Own as much as you can. Then wait.
    30 Jan 2014, 07:47 PM Reply Like
  • Rob Close
    , contributor
    Comments (75) | Send Message
    I know many people hear your words and think "pumper, whatever..."
    But I completely agree. It was a bargain at $8.20, and a steal at anything under IPO value right now. Very few companies present as much growth potential as Solazyme. Here were my thoughts on SZYM a couple months ago:
    30 Jan 2014, 10:31 PM Reply Like
  • pg4u
    , contributor
    Comments (14) | Send Message
    Long $SZYM.. $GEVO is next in line...
    We have to invest for 5 years and it will be either zero or 10x of investments for this short of company...
    30 Jan 2014, 10:48 PM Reply Like
  • hatvani
    , contributor
    Comments (219) | Send Message
    IPO was over 2 years ago and we are yet to touch those prices ever since. I'm long SZYM and have been since the IPO averaging down, but this wait it way too long as other great deals are passing by.
    31 Jan 2014, 02:27 AM Reply Like
  • Str8ghtShooter
    , contributor
    Comments (138) | Send Message
    As posted on Jan. 28, 2014. All I can say is, it's about time. Congratulations to those who are patient and believe in this stock. Much more good news to come.


    I am amazed that the last two CC announcements related to production at Clinton hasn't been a catalyst to take the stock much higher.


    - What are institutional investors waiting for regarding news out of Clinton that would support major share acquisition?
    - Likewise, with the short interest up to nearly 10 million shares, what are the hedge funds waiting for regarding news out of Clinton that would start a massive short covering?
    August 2012 CC: The ADM facility is fully permitted for the initial targeted volume up to 20,000 metric tons, and we're moving forward with our [accelerated] start-up production activity.


    Nov 2013 CC: Commissioning of the 20,000 metric ton facility at Clinton and Galva has gone very well and we remain ahead of our original plan. Specifically we’re producing oils in all of the large scale equipment somewhat routinely now, having demonstrated in the third quarter that both the upstream at Clinton and the downstream at the Galva Iowa facility owned by our partner ANP are working.


    With those processes we are seeing completely linear scale up from the bench to pilot all the way through the commercial in Clinton. Now we will be continuing to put more pressure on the performance conditions as we move forward... we've already demonstrated that we can already run different oils in that facility which is a big deal from our perspective. And we actually have a third one planned before the end of the year. So we’re putting lot of energy and is proving out at a very large scale that software hardware model works and we have the flexibility that we’ve always envisioned in large scale commercial operations.


    Last CC transcript can be found here:
    30 Jan 2014, 10:59 PM Reply Like
  • Str8ghtShooter
    , contributor
    Comments (138) | Send Message
    And then came the news on Jan 31


    Like clockwork.


    Moema is next.
    1 Feb 2014, 12:43 PM Reply Like
  • Mario Kool
    , contributor
    Comments (2) | Send Message
    Although not an investor in Solazyme, but a great fan of such technology and applications I want to add that the JV with Bunge (SBOils) in Brazil is in final steps of erection; I visited the site on Jan 20th for analysis automation and could appreciate the "beehive" it is like, so commissioning and start up are very close. SBOils is putting what is top in technology, automation and materials in there. Works are highly motivated, a great team put together over there. In my view, there will be not enough product (fine oils) for demand out of these 2 (or 3) plants in a couple of years time. Looking forward for more of these plants around in coming years!


    Mario Kool
    31 Jan 2014, 07:32 AM Reply Like
    , contributor
    Comments (34) | Send Message
    I see that there's already some rise in the share price but long-term Solarzyme holders should not be discouraged if the rise isn't as big or as long-lasting as we hope. The traders, analysts and prudent investors will be waiting until they have documentation that the whole operation is making money. They're willing to miss the initial increase in share price in return for the increase in certainty of success. They're probably smarter than we are because we will have missed out on other opportunities in exchange for our bragging rights about how low we got in and how long we've been in. And there's still plenty of room for error before we see dividends and 10 times share prices. I believe we will see them and more and that the wait will ultimately be worth it. Keep the faith.
    31 Jan 2014, 09:32 AM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs